Comparison between Dr.Lal PathLabs IPO and S H Kelkar IPO.
Dr.Lal PathLabs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while S H Kelkar IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Dr.Lal PathLabs IPO is up to ₹631.91 Cr whereas the issue size of the S H Kelkar IPO is up to ₹508.17 Cr. The final issue price of Dr.Lal PathLabs IPO is ₹550.00 per share and of S H Kelkar IPO is ₹180.00 per share.
| Dr.Lal PathLabs IPO | S H Kelkar IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹173.00 per share |
| Issue Price (Upper) | ₹550.00 per share | ₹180.00 per share |
| Issue Price (Final) | ₹550.00 per share | ₹180.00 per share |
| Discount (Retail) | ₹15.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 20 shares | 80 shares |
| Fresh Issue Size | 0 shares | 1,16,66,666 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹210.00 Cr |
| OFS Issue Size | 1,16,00,000 shares | 1,65,65,161 shares |
| OFS Issue Size (Amount) | up to ₹631.91 Cr | up to ₹298.17 Cr |
| Issue Size Total | 1,16,00,000 shares | 2,82,31,827 shares |
| Issue Size Total (Amount) | up to ₹631.91 Cr | up to ₹508.17 Cr |
Dr.Lal PathLabs IPO opens on Dec 08, 2015, while S H Kelkar IPO opens on Oct 28, 2015. The closing date of Dr.Lal PathLabs IPO and S H Kelkar IPO is Dec 10, 2015, and Oct 30, 2015, respectively.
| Dr.Lal PathLabs IPO | S H Kelkar IPO | |
|---|---|---|
| Anchor Bid Date | Dec 07, 2015 | Oct 27, 2015 |
| Issue Open | Dec 08, 2015 | Oct 28, 2015 |
| Issue Close | Dec 10, 2015 | Oct 30, 2015 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 23, 2015 | Nov 16, 2015 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dr.Lal PathLabs IPO P/E ratio is , as compared to S H Kelkar IPO P/E ratio of .
| Dr.Lal PathLabs IPO | S H Kelkar IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.67 | 64.2 | ||||
| Promoter Shareholding (Post-Issue) | 58.7 | 56.71 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹4545.46 Cr. | ₹2603.17 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 27.85% | 17.7% |
In the Dr.Lal PathLabs IPO Retail Individual Investors (RII) are offered 40,60,000 shares while in S H Kelkar IPO retail investors are offered 40,60,000 shares. Qualified Institutional Buyers (QIB) are offered 23,20,000 shares in Dr.Lal PathLabs IPO and 56,46,366 shares in S H Kelkar IPO.
| Dr.Lal PathLabs IPO | S H Kelkar IPO | |
|---|---|---|
| Anchor Investor Reservation | 34,80,000 shares | 84,69,547 shares |
| Market Maker Reservation | ||
| QIB | 23,20,000 shares | 56,46,366 shares |
| NII | 17,40,000 shares | 42,34,774 shares |
| RII | 40,60,000 shares | 98,81,140 shares |
| Employee | ||
| Others | ||
| Total | 1,16,00,000 shares | 2,82,31,827 shares |
Dr.Lal PathLabs IPO subscribed 33.41x in total, whereas S H Kelkar IPO subscribed 27.00x.
| Dr.Lal PathLabs IPO | S H Kelkar IPO | |
|---|---|---|
| QIB (times) | 63.56x | 25.55x |
| NII (times) | 61.28x | 87.38x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.24x | 1.98x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 33.41x | 27.00x |
